Can the Use of Intra Arterial Vasodilators Prevent Radial Artery Occlusion?

The incidence of post procedure radial occlusion (RAO) ranges from 1% to 12 % according to some studies. Different strategies to reduce RAO include the use of small caliber catheters, adequate anticoagulation and punction site care after procedure. 

¿Es útil el uso de vasodilatadores intra-arteriales para prevenir la oclusión de la arteria radial?

Vasodilators are used to prevent radial spasm during procedure. However, using it after procedure should increase flow, improving hemostasis, and preventing RAO. 

The aim of this prospective, multicenter, randomized, double blind study was to assess whether the administration of nitroglycerin at the beginning or at the end of procedure might preserve radial artery patency compared against placebo. 

Primary end point was early RAO incidence confirmed by ultrasound up to 24 hrs. after procedure. Secondary end point was late RAO (30 days after procedure). 

It included 2040 patients. Mean age was 61 and 38% were women. The right radial artery was the most used (99.9%), and catheterization was the most frequent diagnostic procedure. 

Read also: Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus after ST-Segment Elevation Acute Coronary Syndrome

There were no significant differences when looking at primary and secondary end points. The presence of recanalization at 30 days assessed by Doppler was 30% with no differences between the groups.  

At multivariable analysis, the presence of radial spasm and access achieved with more than one puncture attempt were independent predictors of RAO at 24 hrs. 

Conclusion

The use of nitroglycerin was not associated with reduced RAO rate, regardless of time of administration, and therefore it should not be considered mandatory to prevent this complication. 

Dr. Andrés Rodríguez.
Member of the Editorial Board in SOLACI.org .

Original Title: Randomized Clinical Trial on Prevention of Radial Occlusion After Transradial Access Using Nitroglycerin PATENS Trial.

Reference: Roberto L. da Silva, MD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...